Omnicell is trading at $39.50, up 9.87%, ahead of Q3 2026 results scheduled before the October 29 open. - The October 28 close was $35.95; the call is set for 8:30 a.m. ET. - Results were unreleased at 5:04 a.m. ET, so this is earnings anticipation, not a reaction to reported results. - Healthcare was up 1.32% pre-market; the report is the more direct catalyst.